Navigation Links
Diakron Licenses Anticoagulant Drug Candidate from Merck & Co., Inc.
Date:8/13/2008

Orchid Pharma partners with Diakron

MORRIS PLAINS, N.J., Aug. 13 /PRNewswire/ -- Diakron Pharmaceuticals, Inc. announced today the signing of an exclusive license agreement for a novel investigational oral anticoagulant drug candidate discovered and developed through Phase I clinical trials by Merck & Co. Inc. Under the terms of the agreement, Diakron has the exclusive rights to develop, and, if approved, market and distribute the compound worldwide.

In a simultaneous transaction, Orchid Chemicals & Pharmaceuticals Ltd., the Chennai (India) based pharmaceutical major ("Orchid Pharma"), has signed an agreement to partner with Diakron as a significant shareholder and developer for the anticoagulant drug candidate. Orchid will be undertaking the next stages of development.

Announcing the successful conclusion of the agreements, Srirama Rao, PhD., a founder and the Chairman of Diakron said, "We are extremely pleased to be able to license this compound from Merck for further development and commercialization. We are also pleased that Orchid is partnering with us as a significant shareholder and developer of this compound, leveraging its world-class R&D infrastructure in India. This will allow Diakron to fast-track development of this unique anticoagulant product as its number one priority."

Commenting on the agreement, Dr. C.B. Rao, Deputy Managing Director of Orchid stated that partnering with Diakron for the development of this Merck compound is a significant development in Orchid's drug discovery journey. With its end-to-end drug discovery and drug development capability backed by US FDA and UK MHRA compliant manufacturing facilities, Orchid is well positioned to support the development of the compound all the way to successful commercialization, he observed.

"Despite recent advances there remains a significant unmet medical need for novel anticoagulant therapies," said Joseph Vacca, Executive Director of Medic
'/>"/>

SOURCE Diakron Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute
2. Duska Therapeutics Licenses Portfolio of Heart Failure Drugs From Duke and Johns Hopkins
3. Duke Licenses ALPHADAS(R), Logos Technologies EDC System to Accelerate its Early Phase Clinical Trials
4. Genetics Determine Optimal Drug Dose of Common Anticoagulant
5. Nuvelo Initiates Phase 1B Clinical Trial of Anticoagulant NU172
6. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
7. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
8. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
9. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
10. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
11. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Thoratec Corporation ... device-based mechanical circulatory support therapies to save, support and ... in the 2014 Morgan Stanley Global Healthcare Conference on ... , President and Chief Executive Officer, will provide an ... Daylight Time (9:55 a.m., Pacific Daylight Time).   ...
(Date:8/29/2014)... -- According to a new market ... (SFE, Cold Pressed, Organic Solvent, & Others), and by ... & Others) - Global Trends & Forecast to ... Amaranth Seed Oil Market with an analysis and ... value. The Amaranth Seed Oil Market size in ...
(Date:8/29/2014)... DALLAS , August 29, 2014 ... Synthesis Market by Product & Services (Equipment, Reagent, ... Biotechnology), Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, ... by MarketsandMarkets, the global Oligonucleotide Synthesis Market is ... $1,070.7 Million in 2014, growing at a CAGR ...
Breaking Medicine Technology:Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4
... Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ), a ... markets, today announced first quarter 2011 financial results. ... 31, 2011, net revenue was $10.7 million, up from $10.1 ... despite a brief, planned halt in shipments of Acetadote during ...
... NEW YORK, May 4, 2011 Robotic prostatectomy and ... Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive ... appeared on FOX-NY,s Good Day New York to discuss the successes ... benefits it has over other treatment options, making robotic surgery ...
Cached Medicine Technology:Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results 2Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results 3Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results 4Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results 5Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results 6Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results 7Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results 8Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results 9Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results 10Dr. David B. Samadi Discusses Why Robotic Surgery is Quickly Becoming the Go-To Standard for Prostate Cancer Treatment 2Dr. David B. Samadi Discusses Why Robotic Surgery is Quickly Becoming the Go-To Standard for Prostate Cancer Treatment 3
(Date:8/29/2014)... by the Mental Health Commission of Canada identifies ... education that police personnel receive. , "People with ... police community, and today,s report builds on the ... with mental illnesses," says Queen,s adjunct professor Dorothy ... the area of police psychology. "This is a ...
(Date:8/29/2014)... August 29, 2014 Today, Gen. Arthur ... Coalitions of America (CADCA) , the nation’s leading substance ... to President Obama’s intent to nominate Michael Botticelli as ... strongly supports President Obama’s decision to nominate Michael Botticelli ... ideal person to hold this important position at this ...
(Date:8/29/2014)... Thirteen Novant Health registered nurses have ... in North Carolina list by Great 100, Inc., ... to nursing students at all levels across the state. ... Medical Center are: Rea Buie, Carol Caldwell, Susan ... Amber Segerlin, Carmen Smith, Melissa Stafford and Deborah Stegall. ...
(Date:8/29/2014)... Edvance360, a leading provider of eLearning ... teaching, as well as 2011 winner and six-time-finalist for ... System, announced that Brooke Education Services, Northwest Academy, Typewell, ... Advertising Bureau of Canada (IAB Canada), StarSVCS, and HMG ... delighted to welcome each new client to the growing ...
(Date:8/29/2014)... 29, 2014 (HealthDay News) -- Selling cigarettes in plain ... tobacco and doesn,t harm sales in small stores, according ... predicted by the tobacco industry when it tried to ... world to introduce plain packaging for tobacco products in ... Zealand and the U.K. Researchers surveyed nearly 2,000 ...
Breaking Medicine News(10 mins):Health News:Report advocates improved police training 2Health News:CADCA Statement on Nomination of Michael Botticelli as U.S. Drug Czar 2Health News:Great 100 Honors 13 Novant Health Nurses 2Health News:Edvance360 Continues to Experience Growth in Corporate, K-12, Health, and Non-Profit Sectors 2Health News:Study Counters Critics of Plainer Cigarette Packaging 2
... province of Khon Kaen has the world's highest incidence of ... reports said on Monday. ,According to a recent ... three villages of Phai, Mancha Khiri and Channaburi - situated ... north-east of Bangkok - is 118 people per 100,000, the ...
... surgeries are accompanied by complications like abdominal cramping, hernia ... months after the procedure according// to a recent study. ... thousands of dollars to patients' medical bills. ... is considered to be the first in-depth look at ...
... Saddam Hussein will miss the court session of his trial ... of a hunger strike, a court// source said. ... severe health condition after he was hospitalised for mounting a ... the Iraqi Criminal Court told Deutsche Presse-Agentur (DPA) on Monday. ...
... to wait for access to public health care.// ... mandatory three-month waiting period for OHIP coverage for the new ... Smitherman the evacuees have undergone a lot of stress and ... need when they need it the most." ,The ...
... Ministers of Southern States will be held here on ... chikungunya,Karnataka Health Minister R Ashok said today. // ... memorandum to the Centre seeking financial help and release ... government had decided to provide fogging machines to each ...
... carried out by a group of researchers, at the ... between periodontal bacteria and acute// coronary syndrome (ACS). ... alveolar bone loss was significantly greater among those with ... the study participants in the ACS group showed signs ...
Cached Medicine News:Health News:Weight Loss Surgeries Often Accompained by Several Complications 2
Inquire...
... The GENIE is the proven electrophoretic transfer apparatus ... field uniformity. Its design allows for a very ... with a low voltage power source such as ... volts/cm. The result is exceptionally rapid and exact ...
... cassettes, 4 fiber pads, modular electrode assembly, ... with cables, and instructions. The Mini ... mini electrophoresis system (see Mini-Vertical Electrophoresis Systems), ... Its modular electrode assembly transfers two 7.5 ...
... 2 gel holder cassettes, cell ... fiber pads, blot absorbent paper ... Trans-Blot transfer cell, used with ... performs efficient, high-intensity electrophoretic transfers. ...
Medicine Products: